Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial

- Khasraw, Mustafa, Lee, Adrian, McCowatt, Sally, Kerestes, Zoltan, Buyse, Marc E., Back, Michael, Kichenadasse, Ganessan, Ackland, Stephen, Wheeler, Helen

Glioblastoma multiforme: an overview of emerging therapeutic targets

- Taylor, Olivia G., Brzozowski, Joshua S., Skelding, Kathryn A.

Intronic TP53 polymorphisms are associated with increased Δ133TP53 transcript, immune infiltration and cancer risk

- Eiholzer, Ramona A., Mehta, Sunali, Kazantseva, Marina, Drummond, Catherine J., McKinney, Cushla, Young, Katie, Slater, David, Morten, Brianna C., Avery-Kiejda, Kelly A., Lasham, Annette, Fleming, Nicholas, Morrin, Helen R., Reader, Karen, Royds, Janice A., Landmann, Michael, Petrich, Simone, Reddel, Roger, Huschtscha, Lily, Taha, Ahmad, Hung, Noelyn A., Slatter, Tania L., Braithwaite, Antony W.

Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme

- Griffin, Cassandra, Vilain, Ricardo, King, Simon, Nixon, Sandy, Gooley, Alisha, Bray, Samara, Lynam, James, Walker, Marjorie M., Scott, Rodney J., Paul, Christine

Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma

- Head, R. J., Fay, M. F., Cosgrove, L., Y C Fung, K., Rundle-Thiele, D., Martin, J. H.

Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole

- Griffin, Cassandra P, Paul, Christine L, Alexander, Kimberley L, Walker, Marjorie M, Hondermarck, Hubert, Lynam, James

Repurposing some older drugs that cross the blood-brainier and have potential anticancer activity to provide new treatment options for glioblastoma

- Rundle-Thiele, Dayle, Head, Richard, Cosgrove, Leah, Martin, Jennifer H.

Short-course radiation plus temozolomide in elderly patients with glioblastoma

- Perry, James R., Laperriere, Normand, Osoba, David, Rossiter, John P., Sahgal, Arjun, Hirte, Hal, Laigle-Donadey, Florence, Franceschi, Enrico, Chinot, Olivier, Golfinopoulos, Vassilis, Fariselli, Laura, Wick, Antje, O'Callaghan, Christopher J., Brandes, Alba A., Menten, Johan, Phillips, Claire, Fay, Michael, Nishikawa, Ryo, Cairncross, J. Gregory, Roa, Wilson

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

- Climans, Seth A., Brandes, Alba A., Phillips, Claire, Roa, Wilson, Wick, Wolfgang, Winch, Chad, Mason, Warren P., Cairncross, J. Gregory, Ding, Keyue, Fay, Michael, Laperriere, Normand, Menten, Johan, Nishikawa, Ryo, O'Callaghan, Christopher J., Perry, James R.

The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells

- Hosein, Abdel Nasser, Lim, Yi Chieh, Day, Bryan, Stringer, Brett, Rose, Stephen, Head, Richard, Cosgrove, Leah, Sminia, Peter, Fay, Michael, Martin, Jennifer H.

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method

- Rundle-Thiele, Dayle, Day, Bryan, Coulthard, Alan, Crozier, Stuart, Rose, Stephen, Stringer, Brett, Fay, Michael, Martin, Jennifer, Jeffree, Rosalind L., Thomas, Paul, Bell, Christopher, Salvado, Oliver, Gal, Yaniv

Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?

- Fay, Michael, Head, Richard, Martin, Jennifer